Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a named patient programme at a single UK center
Authors
Gibb, AdamJones, Craig
Bloor, Adrian
Kulkarni, Samar
Illidge, Timothy M
Linton, Kim M
Radford, John A
Affiliation
The Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester, M20 9BX, UKIssue Date
2013
Metadata
Show full item recordCitation
Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a named patient programme at a single UK center 2012, 98 (4):611 HaematologicaJournal
HaematologicaDOI
10.3324/haematol.2012.069393Additional Links
http://www.haematologica.org/cgi/doi/10.3324/haematol.2012.069393Type
ArticleLanguage
enISSN
0390-60781592-8721
ae974a485f413a2113503eed53cd6c53
10.3324/haematol.2012.069393